In addition, by RNA-sequencing analysis of crizotinib-resistant ALCL cells we found that CD45 mRNA was significantly downregulated in the crizotinib-resistant cells compared to the sensitive counterpart. The gene discussed is PTPRC; the disease is anaplastic large cell lymphoma.